HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Facon Selected Research

Monoclonal Antibodies

1/2023Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
12/2022Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.
1/2021Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.
1/2020Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
5/2018Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma.
5/2016Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Facon Research Topics

Disease

171Multiple Myeloma
03/2024 - 01/2002
25Disease Progression
03/2024 - 06/2005
15Neoplasms (Cancer)
04/2023 - 10/2003
11Peripheral Nervous System Diseases (PNS Diseases)
10/2021 - 03/2009
9Residual Neoplasm
03/2024 - 12/2016
8Infections
01/2021 - 01/2006
7Pneumonia (Pneumonitis)
11/2021 - 01/2016
7Neutropenia
11/2021 - 11/2007
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2007 - 02/2002
6Chromosome Aberrations (Chromosome Abnormalities)
03/2024 - 03/2002
6Frailty
11/2023 - 01/2020
6Hematologic Neoplasms (Hematological Malignancy)
11/2023 - 11/2005
6Thrombocytopenia (Thrombopenia)
11/2020 - 11/2007
4Lymphopenia (Lymphocytopenia)
11/2021 - 01/2019
4Hypertension (High Blood Pressure)
10/2021 - 01/2016
4Fatigue
11/2020 - 02/2003
4Anemia
01/2019 - 01/2006
3Pain (Aches)
10/2021 - 05/2002
3Heart Failure
09/2019 - 02/2003
3Heart Arrest (Cardiac Arrest)
09/2019 - 10/2017
3Neoplasm Metastasis (Metastasis)
04/2008 - 02/2003
3Breast Neoplasms (Breast Cancer)
01/2008 - 02/2003
3Bone Resorption
02/2006 - 05/2002
2Drug-Related Side Effects and Adverse Reactions
11/2023 - 08/2013
2Sepsis (Septicemia)
11/2022 - 09/2019
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2021 - 08/2002
2Septic Shock (Toxic Shock Syndrome)
10/2021 - 10/2017
2Carcinogenesis
01/2020 - 09/2002
2Vomiting
01/2019 - 03/2012
2Agammaglobulinemia (Hypogammaglobulinemia)
01/2019 - 06/2008
2Lymphoma (Lymphomas)
04/2016 - 11/2005
2Plasma Cell Leukemia
01/2016 - 03/2002
2Venous Thromboembolism
10/2013 - 11/2007
2Paraproteinemias (Monoclonal Gammopathy)
03/2013 - 03/2002
2Constipation
05/2012 - 03/2012
2Herpes Zoster
10/2008 - 02/2003
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2008 - 06/2008
2Osteonecrosis (Kienbock's Disease)
04/2008 - 01/2008
2Monoclonal Gammopathy of Undetermined Significance
10/2007 - 10/2005
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2007 - 10/2003
1Bites and Stings (Sting)
10/2020
1Amyloidosis
01/2020

Drug/Important Bio-Agent (IBA)

85Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 06/2005
55Bortezomib (Velcade)FDA Link
03/2024 - 06/2005
48Lenalidomide (CC 5013)FDA Link
03/2024 - 11/2007
30Thalidomide (Thalomid)FDA Link
10/2021 - 01/2002
24Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 02/2002
19carfilzomibIBA
03/2024 - 05/2015
18Prednisone (Sone)FDA LinkGeneric
01/2022 - 03/2002
16daratumumabIBA
03/2024 - 01/2019
15pomalidomideIBA
11/2023 - 03/2013
12isatuximabIBA
03/2024 - 01/2021
9Proteasome InhibitorsIBA
11/2022 - 11/2005
8selinexorIBA
01/2023 - 01/2019
8Imatinib Mesylate (Gleevec)FDA Link
10/2011 - 02/2002
7Immunomodulating AgentsIBA
11/2022 - 11/2010
6Monoclonal AntibodiesIBA
01/2023 - 05/2016
5Proteins (Proteins, Gene)FDA Link
04/2023 - 12/2016
5Biomarkers (Surrogate Marker)IBA
12/2021 - 02/2003
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2023 - 07/2014
4B-Cell Maturation AntigenIBA
01/2022 - 01/2020
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018 - 08/2013
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 02/2003
4Immunoglobulins (Immunoglobulin)IBA
12/2014 - 03/2002
4Proteasome Endopeptidase Complex (Proteasome)IBA
03/2009 - 11/2005
3Diphosphonates (Bisphosphonates)IBA
04/2008 - 05/2002
3bcr-abl Fusion ProteinsIBA
12/2003 - 02/2002
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2003 - 08/2002
2Chimeric Antigen ReceptorsIBA
01/2022 - 12/2019
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022 - 10/2021
2ixazomibIBA
01/2022 - 01/2021
2venetoclaxIBA
01/2021 - 11/2017
2elotuzumabIBA
12/2015 - 06/2012
2Immunologic Factors (Immunomodulators)IBA
01/2013 - 12/2012
2Immunoglobulin M (IgM)IBA
06/2008 - 06/2008
2AlbuminsIBA
10/2007 - 02/2003
2HLA-G Antigens (HLA G)IBA
10/2005 - 10/2003
2OsteoprotegerinIBA
06/2005 - 02/2003
2Cytarabine (Cytosar-U)FDA LinkGeneric
12/2003 - 04/2003
1Adenosine Monophosphate (AMP)IBA
03/2024
1plerixaforFDA Link
03/2023
1iberdomideIBA
11/2022
1idecabtagene vicleucelIBA
01/2022
1VaccinesIBA
12/2021
1PENTAIBA
09/2021
1vendexIBA
01/2021
1Exportin 1 ProteinIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2020
1belantamab mafodotinIBA
01/2020
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1vasectrin IIIIBA
01/2020

Therapy/Procedure

73Therapeutics
03/2024 - 01/2002
24Stem Cell Transplantation
11/2021 - 02/2002
11Drug Therapy (Chemotherapy)
11/2021 - 05/2002
9Transplantation
01/2022 - 05/2007
3Salvage Therapy
01/2023 - 06/2009
2Radiotherapy
02/2003 - 05/2002
1Retreatment
10/2021
1Palliative Care (Palliative Therapy)
01/2021
1Intravenous Infusions
01/2020